Federal Circuit: PTAB Decision of Invalidity Cannot Estop District Court Litigation on Different Claims from the Same Patent, Even When the Claims are Patentably Indistinct

April 23, 2025

Reading Time : 2 min

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to invalidate claims in district court.

In this case, the patentee filed suit in the District of Delaware alleging infringement of 13 exemplary claims of a patent generally directed to incentive programs over a computer network. The defendant responded by challenging 21 claims of the asserted patent over two IPR proceedings. In the IPRs, the PTAB found all of the challenged claims unpatentable, and the Federal Circuit summarily affirmed that decision.

After the statutory deadline passed for defendant to file additional IPR petitions, the patentee amended its complaint to assert different, unchallenged claims from the same patent. Defendant moved to dismiss the amended complaint, arguing that the patentee was collaterally estopped from asserting the new claims in view of the PTAB and Federal Circuit decisions. The district court granted the motion to dismiss. According to the district court, the decision turned on whether the issues decided by the PTAB were identical to the issues raised in the district court. The district court found the newly asserted claims “immaterially different” from the claims challenged in IPR, and therefore determined that the issues before both tribunals were identical. Thus, collateral estoppel applied to the newly asserted claims because they “do not materially alter the question of invalidity.”

On appeal, the Federal Circuit reversed. The Federal Circuit acknowledged that the district court applied the correct legal framework for collateral estoppel, but reversed because the district court overlooked the well-known exception to collateral estoppel—when the actions involve the application of different legal standards, such as different burdens of proof, collateral estoppel does not apply. Because the PTAB applies the preponderance standard while district courts apply the clear and convincing standard to questions of invalidity, the PTAB’s unpatentability determinations regarding different claims necessarily fall within this exception. And as a result, there can be no collateral estoppel in a case like this where the claims reviewed by the PTAB are different from the claims asserted in district court.

The Federal Circuit likened this case to its decision in ParkerVision, Inc. v. Qualcomm Inc., where it reversed a district court’s decision to limit expert testimony regarding the validity of method claims from a patent where the PTAB previously found the apparatus claims of the same patent invalid. 116 F.4th 1345, 1360–61 (Fed. Cir. 2024). There too, the Federal Circuit refused to apply collateral estoppel in view of the differing burdens of proof applied by the PTAB and district court.

In reaching this decision, the Federal Circuit also distinguished prior case law, explaining that even though collateral estoppel does not apply in this case because the amended complaint asserted different claims than those found unpatentable in the IPR, that does not mean claims found unpatentable in an IPR (and affirmed by the Federal Circuit) can be asserted in district court. Those claims are barred from district court litigation because, as a ministerial matter, they no longer exist, i.e., they have been cancelled as a matter of law.

Practice tip: While a prior invalidity ruling from district court can be used to collaterally estop a patentee from asserting new, but immaterially different claims in district court, patentability determinations in an IPR cannot. This decision highlights the potential limitations of IPRs, particularly for patents that contain numerous claims.

Kroy IP Holdings, LLC v. Groupon, Inc., No. 2023-1359, 2025 WL 440509 (Fed. Cir. Feb. 10, 2025)

Share This Insight

Previous Entries

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

IP Newsflash

April 23, 2025

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to invalidate claims in district court.

...

Read More

IP Newsflash

April 7, 2025

The Central District of California denied a defendant’s motion to dismiss or transfer plaintiff’s first-filed declaratory judgment action based on defendant’s later-filed patent infringement suit in Wisconsin.  Though suit was seemingly imminent when defendant advised plaintiff it might be infringing defendant’s patents, plaintiff responded by requesting a licensing agreement in lieu of litigation. The court found that plaintiff’s action was not anticipatory forum-shopping litigation because plaintiff only filed suit after defendant neglected to respond to its licensing offer.

...

Read More

IP Newsflash

April 1, 2025

The District of Delaware recently denied in part a motion to compel production of documents and testimony between a patentee and potential investors, valuation firms and an international bank based on the common interest exception. In so doing, the court reaffirmed that disclosure of privileged information to third parties will generally waive privilege unless it can be shown that the parties’ interests are identical and the communications are legal, not solely commercial.

...

Read More

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.